Compositions and devices for controlled release of active ingredients

• US 5,607,417 A
• Filed: 02/01/1995
• Issued: 03/04/1997
• Est. Priority Date: 02/01/1994
• Status: Expired due to Fees

• Current Assignee: Caphco Incorporated
• Original Assignee: Caphco Incorporated
• Inventors: Batich, Christopher D., Cohen, Marc S., Foster, Kirk
• Primary Examiner(s): McDermott, Corrine M.
• Assistant Examiner(s): SMITH, CHALIN A
• Application Number:
  US08/382,315
• Time in Patent Office: 762 Days
• Field of Search: 424/423, 604/890.1, 604/891.1, 604/892.1, 604/285, 604/265-266, 604/904.11
• US Class Current: 604/890.1
• CPC Class Codes: A61K 31/57 substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
• CPC Class Codes: A61K 9/2027 obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
• CPC Class Codes: A61L 2300/404 Biocides, antimicrobial agents, antiseptic agents
• CPC Class Codes: A61L 2300/602 Type of release, e.g. controlled, sustained, slow
• CPC Class Codes: A61L 2300/606 Coatings
• CPC Class Codes: A61L 27/34 Macromolecular materials
• CPC Class Codes: A61L 27/54 Biologically active materials, e.g. therapeutic substances A61L27/227 takes precedence
• CPC Class Codes: A61L 29/085 Macromolecular materials
• CPC Class Codes: A61L 29/16 Biologically active materials, e.g. therapeutic substances A61L29/048 takes precedence
• CPC Class Codes: A61L 31/16 Biologically active materials, e.g. therapeutic substances A61L31/047 takes precedence
• CPC Class Codes: C08L 33/02 Homopolymers or copolymers of acids; Metal or ammonium salts thereof
• CPC Class Codes: C08L 33/06 of esters containing only carbon, hydrogen and oxygen, which oxygen atoms are present only as part of the carboxyl radical

Abstract

A method for the controlled release of a biologically active agent wherein the agent is released from a hydrophobic, pH-sensitive polymer matrix is disclosed and claimed. The polymer matrix swells when the environment reaches pH 8.5, releasing the active agent. A polymer of hydrophobic and weakly acidic comonomers is disclosed for use in the controlled release system. Further disclosed is a specific embodiment in which the controlled release system may be used. The pH-sensitive polymer is coated onto a latex catheter used in ureteral catheterization. A common problem with catheterized patients is the infection of the urinary tract with ureaseproducing bacteria. In addition to the irritation caused by the presence of the bacteria, urease produced by these bacteria degrade urea in the urine, forming carbon dioxide and ammonia. The ammonia causes an increase in the pH of the urine. Minerals in the urine begin to precipitate at this high pH, forming encrustations which complicate the functioning of the catheter. A ureteral catheter coated with a pH-sensitive polymer having an antibiotic or urease inhibitor trapped within its matrix will release the active agent when exposed to the high pH urine as the polymer gel swells. Such release can be made slow enough so that the drug remains at significant levels for a clinically useful period of time.

Claims

1. An indwelling medical device which controls, which indicates, or which both controls and indicates a bacterial infection which causes a change in the pH of the environment of said indwelling medical device, wherein said indwelling medical device comprises a pH-sensitive polymer matrix coating in which a biologically active agent is trapped and integrally incorporated, said agent being released from said polymer matrix coating at an increased rate or only upon said change of pH, wherein said change in pH causes said pH-sensitive polymer matrix to swell to release said biologically active agent trapped within said pH-sensitive polymer matrix.

2. The device, according to claim 1, which is a catheter or stent.

3. The device of claim 1 wherein said biologically active agent is a dye.

4. The device, according to claim 1, wherein said pH-sensitive polymer comprises a weakly acidic monomer.

5. The device, according to claim 4, wherein said weakly acidic monomer is selected from the group consisting of methacrylic acid and acrylic acid.

6. The device, according to claim 4, wherein said pH-sensitive polymer further comprises a hydrophobic monomer selected from the group consisting of butylmethyl acrylate and methyl methacrylate.

7. A method for controlling, indicating or both controlling and indicating a bacterial infection associated with the use of an indwelling medical device in an environment which is desired to be kept free of bacterial infection, wherein said infection causes or would cause a change in the pH of the environment of said indwelling medical device, wherein said method comprises;

implanting into a patient an indwelling medical device, said device being coated with a pH-sensitive polymer matrix within which there is trapped and integrally incorporated a biologically active agent, wherein said polymer matrix swells to release said agent at an increased rate or only upon said change in pH, thereby indicating, controlling or indicating and controlling said infection.

8. The method of claim 7 wherein said biologically active agent is a dye.

9. The method, according to claim 7, further comprising selecting said medical device from the group consisting of ureteral or urethral catheters or stents, heart valves, pacemakers, artificial joints, gastrointestinal tubes, intrauterine devices, and diaphragms.

10. The method, according to claim 9, wherein said environment is urine and said pH is greater than about 8.5.